Dec. 10, 2021

Discovery Platform for Small Molecule mRNA Drugs like no other: mRNA Lightning, from Anima Biotech

Discovery Platform for Small Molecule mRNA Drugs like no other: mRNA Lightning, from Anima Biotech

For the computer expert/CEO of Anima, Yochi Slonim, it’s all the same – lots of instructions and lots of code. It could be code for AI, it could be codons for the translation of proteins. With the elucidation of unique codon pairings by mRNA Lightning, Slonim can turn expression on or off, or up or down, depending on the therapeutic need, like say, in CNS disorders. Eli Lilly has taken notice. So has Takeda. You might want to give a listen…